Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2025-12-24 @ 5:23 PM
NCT ID:
NCT02403050
Eligibility Criteria:
Inclusion Criteria:
* esophageal adenocarcinoma or squamous carcinoma, or undifferentiated carcinoma.
* No previous radiotherapy or chemotherapy.
* Fit for radical treatment of their cancer with reasonable lung function, Fev1 \>40%, and EUS planned.
* ECOG Performance Status 0-1: 0 - Fully active, able to carry on all predisease performance without restriction 1 - Restricted in physically strenuous activity
Exclusion Criteria:
* Pregnancy or breast feeding.
* Allergy to ciprofloxacin antibiotics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02403050
Study Brief:
Protocol Section:
NCT02403050